![]() |
市场调查报告书
商品编码
1380388
全球软胶囊市场2023-2030Global Softgel Capsule Market 2023-2030 |
由于软胶囊的优点、膳食补充剂和营养保健品的需求不断增加、对天然成分和易消化溶解品质的需求不断增加,预计全球软胶囊市场在预测期内将以 6.2% 的CAGR增长。几分钟到达胃部。食用总是很容易,因为它们具有光滑的质地。它们比片剂、囊片和其他药丸更容易吞嚥。具有令人讨厌的气味或味道的悬浮液可以轻鬆地以软明胶胶囊剂型摄入,提供有序的外观和适当的摄入。
全球软胶囊市场根据材料类型、应用和类别进行细分。根据材料类型,市场分为动物性和非动物性。根据应用,市场细分为药品、营养保健品和膳食补充剂以及化妆品和个人护理品。根据类别,市场分为品牌製造商和合约製造商。在材料类型中,基于动物的子细分市场预计将占据相当大的市场份额,因为它具有保水能力、熔点较高、生产时间更快、成本低以及最大限度地减少製造过程中潜在的粉尘产生,从而提高了生产效率。生产人员的安全。猪组织用于生产绝大多数软胶囊,使该行业拥有更大的市场份额。
在这些应用中,营养保健品和膳食补充剂细分市场预计将占据相当大的市场份额,并预计在预测期内将以可观的CAGR增长。骨关节炎发生率的上升增加了对草药营养保健品的需求,以对抗发炎的影响。此外,人们对健康和个人护理的认识不断增强,以及以 Z 世代为特征的人群也推动了对营养保健品和补充剂的需求。全球营养保健品和补充剂市场在过去十年中稳步增长,据报导2019 年价值近3530 亿美元。在大流行之前的美国,2019 年膳食补充剂销售额比上年增长了5%(3.45 亿美元)年。营养保健品可有效减少肥胖、改善肌肤并帮助治疗癌症。健康和健身领域加强了市场扩张。随着消费者持续高度重视自己的健康,零售商和生产商更加意识到消费者对营养保健品产业需求的变化。当维生素被製成片剂或软糖时,很容易在大气中氧化和降解。因此,软胶囊是最好的配方选择,因为它们可以防止紫外线辐射和氧化,最终提高其保质期。维生素以软胶囊形式服用时,比片剂形式更能更快被血液吸收。由于这些优点,维生素主要以软胶囊形式出售。
全球软胶囊市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,北美由于存在大量的软胶囊市场,在全球软胶囊市场中占有重要份额。软胶囊产品供应商的数量。此外,该国老牌企业为扩大其产品组合而不断增加的研发活动将进一步推动美国全球软胶囊市场的成长。
在所有地区中,亚太地区预计在预测期内全球将以显着的CAGR成长。这主要归因于中国和印度仿製药製造商的大量存在、对具有成本效益的治疗药物的需求不断增加、这些国家人口众多以及经济状况的迅速改善。此外,该地区合约製造组织的兴起也是其高速成长的因素。 2021年中国医药企业合併营业收入年增18.7%,创五年来最高增速。 2021 年,该行业的公司合计收入达 5,020 亿美元。该区域市场的扩张是由不断扩大的亚洲科学基础和能力、亚洲医药市场和药品製造能力的扩张以及亚洲各地庞大的患者群体推动的。太平洋国家。由于亚太地区巨大的成长潜力和较低的製造成本,许多国际製药公司正在亚太地区建设生产设施或扩大其现有设施。
服务软胶囊市场的主要公司包括: Nitta Gelatin India Ltd、Fuji Capsule Co., Ltd.、Aenova Holding GmbH、GELITA AG、ITALGEL Srl、Catalent, Inc、Sirio Pharma Co.,Ltd。和别的。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2020年10月,康泰伦特宣布推出OptiGel DR技术,用于肠溶软胶囊的配方与製造。该技术允许透过将果胶(一种天然衍生的多醣)与明胶相结合来形成软胶囊,从而无需单独的胶囊包衣步骤。
Title: Global Softgel Capsule Market Size, Share & Trends Analysis Report by Material Type (Animal Based and Non-Animal based), by Application (Pharmaceuticals, Nutraceutical and Dietary Supplements and Cosmetics & Personal Care) and By Category (Brand manufacturer and Contract Manufacturer),Forecast Period (2023-2030).
The global softgel capsule market is anticipated to grow at a considerable CAGR of 6.2% during the forecast period owing to benefits of softgel capsules, increasing demand for dietary supplements and nutraceuticals, rising demand for naturally sourced ingredients and have the quality of easy digest dissolving within a few minutes of reaching the stomach. Consuming is always easy as they have a smooth texture. They are more accessible to gulp down than tablets, caplets, and other pills. Suspensions with an unlikable smell or flavor can be easily ingested in a soft gelatin capsule dosage form, offering an orderly exterior and suitable ingestion.
The global softgel capsule market is segmented on the basis of material type, application and category. Based on the material type, the market is sub-segmented into animal based and non-animal based. Based on the application, the market is sub-segmented into pharmaceuticals, nutraceutical and dietary supplements and cosmetics & personal care. Based on the category the market is sub-segmented into brand manufacturer and contract manufacturer. Among the material type, animal based sub-segment is anticipated to hold a considerable share of the market owing to capacity to hold water, higher melting point, and faster production time, low cost and minimizing potential generation of dust during manufacturing and thereby improving the safety of production personnel. Porcine tissues are used to produce a vast majority of softgel capsules, resulting in a bigger market share for this sector.
Among the application, the nutraceutical and dietary supplements sub-segment is expected to hold a considerable share of the market and is further anticipated to grow at a considerable CAGR over the forecast period. Rising incidences of osteoarthritis have augmented the demand for nutraceuticals made of herbs to counter the effects of inflammation. Additionally growing awareness regarding health and personal care and the population group characterized as Gen Z has propelled the demand for nutraceuticals and supplements. The global nutraceuticals and supplements market has steadily grown over the past decade and was reported to be worth almost $353 billion in 2019. In the US prior to the pandemic, dietary supplement sales increased by 5% ($345 million) in 2019 compared to the previous year. Nutraceutical products are effective in reducing obesity, improving skin, and aiding in the treatment of cancer. The market expansion has been reinforced by the health and fitness sectors. Retailers and producers are more aware of consumers changing demands in the nutraceuticals sector as consumers continue to place a high priority on their health. Vitamins are prone to atmospheric oxidation and degradation when formulated as tablets or gummies. Hence, softgel capsules are the best formulation option, as they offer protection from UV radiation and oxidation, ultimately improving their shelf life. Vitamins, when taken in softgel capsule form, are more rapidly absorbed in the bloodstream than in a tablet form. Owing to such advantages, vitamins are majorly sold in the softgel capsule form.
The global Softgel capsule market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America to hold a significant share of the global softgel capsule market owing to the presence of a large number of suppliers for softgel capsule products. Additionally, the increasing research and development activities by the established players in the country to expand their product portfolio will further propel the growth of the global softgel capsules market in the US.
Among all regions, the Asia-Pacific region is expected to grow at a prominent CAGR over the forecast period, globally. This can be attributed mostly to enormous presence of generic medicine manufacturers in China and India, increasing demand for cost-efficient therapeutics, large population in these countries, and rapidly improving economic conditions. Additionally rise in contract manufacturing organizations within the region, are factors responsible for its high growth. China's pharmaceutical firms saw their combined business revenue climb 18.7% year on year in 2021, the highest growth rate in five years. Companies in this sector together raked in $502 billion in 2021. The expansion of this regional market is being driven by the expanding Asian scientific base and competence, the expansion of the Asian pharmaceutical market and pharmaceutical manufacturing capabilities, and the sizable patient pool in various Asia Pacific nations. Numerous international pharmaceutical firms are building production facilities in the Asia Pacific region or expanding their current facilities because of the region's enormous growth potential and low manufacturing costs.
The major companies serving the Softgel capsule market include: Nitta Gelatin India Ltd, Fuji Capsule Co., Ltd., Aenova Holding GmbH, GELITA AG, ITALGEL S.r.l., Catalent, Inc, Sirio Pharma Co.,Ltd. and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2020, Catalent announced the launch of OptiGel DR technology for the formulation and manufacture of enteric release softgels. The technology allows softgel capsules to be formed by combining pectin, a naturally derived polysaccharide, with gelatin, eliminating the need for a separate capsule coating step.